Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
ZimVie Inc (ZIMV)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: ZIMV (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $19
1 Year Target Price $19
| 1 | Strong Buy |
| 0 | Buy |
| 2 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -16.13% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 531.02M USD | Price to earnings Ratio - | 1Y Target Price 19 |
Price to earnings Ratio - | 1Y Target Price 19 | ||
Volume (30-day avg) 4 | Beta 2.08 | 52 Weeks Range 8.15 - 18.98 | Updated Date 08/15/2025 |
52 Weeks Range 8.15 - 18.98 | Updated Date 08/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.69 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-07-30 | When - | Estimate 0.23 | Actual 0.26 |
Profitability
Profit Margin -4.39% | Operating Margin (TTM) 3.33% |
Management Effectiveness
Return on Assets (TTM) 0.51% | Return on Equity (TTM) -4.76% |
Valuation
Trailing PE - | Forward PE 23.31 | Enterprise Value 695388719 | Price to Sales(TTM) 1.2 |
Enterprise Value 695388719 | Price to Sales(TTM) 1.2 | ||
Enterprise Value to Revenue 1.57 | Enterprise Value to EBITDA 16.21 | Shares Outstanding 28200900 | Shares Floating 22050880 |
Shares Outstanding 28200900 | Shares Floating 22050880 | ||
Percent Insiders 2.61 | Percent Institutions 88.62 |
Upturn AI SWOT
ZimVie Inc
Company Overview
History and Background
ZimVie Inc. was founded in 2022 as a spin-off from Zimmer Biomet. Its focus is on dental and spine products, creating a dedicated entity for these segments.
Core Business Areas
- Dental: Focuses on developing, manufacturing, and marketing a comprehensive portfolio of dental implants, abutments, and associated surgical products.
- Spine: Focuses on developing, manufacturing, and marketing a broad range of spinal surgery solutions, including implants and biologics.
Leadership and Structure
Vafa Jamali serves as the President and CEO of ZimVie Inc. The company has a typical corporate structure with various departments overseeing different aspects of the business, reporting to executive leadership.
Top Products and Market Share
Key Offerings
- TSX Implant: A dental implant system known for its osseointegration capabilities. Market share data is difficult to obtain independently. Competitors include Straumann (SAUHF), Danaher (DHR), and Dentsply Sirona (XRAY).
- MarrowStim Biologics: A spine biologic product used to stimulate bone growth. Market share data is difficult to obtain independently. Competitors include Medtronic (MDT), Johnson & Johnson (JNJ), and NuVasive (GCOM).
- Vitality Dental Portfolio: Broad line of instruments and drill kits to aid in dental surgical procedures. Market share data is difficult to obtain independently. Competitors include Nobel Biocare (part of Danaher DHR) and Osstem Implant.
Market Dynamics
Industry Overview
The dental and spine industries are growing due to aging populations, increasing demand for cosmetic dentistry, and advancements in surgical techniques. The industry is competitive, with many large and small players.
Positioning
ZimVie Inc. aims to establish itself as a leading provider of dental and spine solutions by focusing on innovation, quality, and customer service. The company faces stiff competition from established players.
Total Addressable Market (TAM)
The total addressable market for dental and spine is in the billions of dollars, with expectations to grow. ZimVie is positioned to compete by creating targeted innovations for the global market.
Upturn SWOT Analysis
Strengths
- Focused dental and spine business
- Strong brand recognition from Zimmer Biomet heritage
- Experienced management team
- Established distribution network
- Innovative technology portfolio
Weaknesses
- Relatively new company
- Smaller scale compared to competitors
- Dependence on Zimmer Biomet for certain services
- Integration challenges post spin-off
- High debt
Opportunities
- Expanding into new geographic markets
- Developing innovative products and services
- Acquiring complementary businesses
- Partnering with other companies
- Increasing market share in existing markets
Threats
- Intense competition
- Pricing pressures
- Regulatory changes
- Economic downturn
- Product liability claims
Competitors and Market Share
Key Competitors
- MDT
- JNJ
- DHR
- XRAY
Competitive Landscape
ZimVie Inc. faces strong competition from established players with greater resources and market share. ZimVie must differentiate itself through innovation, customer service, and strategic partnerships.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data is limited as the company was recently formed.
Future Projections: Future growth projections are based on analyst estimates and company guidance.
Recent Initiatives: Recent initiatives include launching new products, expanding into new markets, and improving operational efficiency.
Summary
ZimVie Inc. is a relatively new company with a focused business strategy. Its reliance on Zimmer Biomet creates some dependency and high debt. Despite this, the company has the opportunity to grow as it differentiates itself through innovation in the dental and spine markets and forms new partnerships. It needs to carefully navigate the competitive landscape and economic pressures.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Company Website
- Analyst Reports
- Industry Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Market share data is based on available estimates and may not be precise. Actual results may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About ZimVie Inc
Exchange NASDAQ | Headquaters Palm Beach Gardens, FL, United States | ||
IPO Launch date 2022-03-01 | President, CEO & Chairman of the Board Mr. Vafa Jamali | ||
Sector Healthcare | Industry Medical Devices | Full time employees 1770 | Website https://www.zimvie.com |
Full time employees 1770 | Website https://www.zimvie.com | ||
ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. The company offers dental implant systems and biomaterials; digital dentistry solutions; restorative and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; intraoral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including dental service organizations, as well as educational, medical and governmental entities, hospitals, and surgery centers through sales representatives, independent sales agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Palm Beach Gardens, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.